Professor Lencioni ILCA 2011.pdf - Biocompatibles

ePAPER READ

DOWNLOAD ePAPER

assets.biocompatibles.com

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

AST Units/LALT Units/LDEBDOX vs cTACE: Drug-related AEs and livertoxicity are markedly reduced300250200p=0.001150p=0.001100500200150DC BeadcTACEp

Drug-Eluting Bead TACE with DC BeadÂ® [DEBDOXâ¢] in the ...

Bead Block embosphere EC10-141 A4 ROW web.pdf - Biocompatibles

IVMPRC12-018 New Bead Block Brochure.pdf - Biocompatibles

DC Bead: In Vitro Characterization of a Drug ... - Biocompatibles

Drug-Eluting Beads Versus Conventional TACE - Biocompatibles

EC12-075(T) Rev 1 Dox M1 brochure.pdf - Biocompatibles

PRECISION V Trial Overview and Initial Data Presentation - Onsite TV

DEBIRI Detail Aid CE Approved spreads.pdf - Biocompatibles

Drug-eluting beads: a pharmaceutical assessment - Biocompatibles

AST Units/LALT Units/LDEBDOX vs cTACE: Drug-related AEs and livertoxicity are markedly reduced300250200p=0.001150p=0.001100500200150DC BeadcTACEp

DEBDOX vs cTACE: Response rates are higherin patients with more advanced diseasep = 0.11Overall response at 6 monthsResponse: subgroup analysisLammer J et al. Cardiovasc Intervent Radiol 2010;33:41-52

Page 1 and 2: Is DEBDOX the New Standardfor Chemo
Page 3 and 4: BCLC staging system and treatment s
Page 5 and 6: Probability of survival (%)Probabil
Page 7 and 8: Conventional TACE: treatment discon
Page 9: Drug eluting bead doxorubicin (DEBD
Page 13 and 14: SongMalagariPoonVarelaLencioniReyes
Page 15: DEBDOX vs conventional Lipiodol TAC

Professor Lencioni ILCA 2011.pdf - Biocompatibles

Create successful ePaper yourself

Delete template?

Save as template?